Rare non-Hodgkin lymphoma of childhood and adolescence

  • Andishe Attarbaschi
  • Oussama Abla
  • Laura Arias Padilla
  • Auke Beishuizen
  • G A Amos Burke
  • Laurence Brugières
  • Julie Bruneau
  • Birgit Burkhardt
  • Emanuele S G d'Amore
  • Wolfram Klapper
  • Udo Kontny
  • Marta Pillon
  • Mary Taj
  • Suzanne D Turner
  • Anne Uyttebroeck
  • Wilhelm Woessmann
  • Karin Mellgren

Abstract

Pediatric-type follicular (PTFL), marginal zone (MZL), and peripheral T-cell lymphoma (PTCL) account each for <2% of childhood non-Hodgkin lymphoma. We present clinical and histopathological features of PTFL, MZL, and few subtypes of PTCL and provide treatment recommendations. For localized PTFL and MZL, watchful waiting after complete resection is the therapy of choice. For PTCL, therapy is subtype-dependent and ranges from a block-like anaplastic large cell lymphoma (ALCL)-derived and, alternatively, leukemia-derived therapy in PTCL not otherwise specified and subcutaneous panniculitis-like T-cell lymphoma to a block-like mature B-NHL-derived or, preferentially, ALCL-derived treatment followed by hematopoietic stem cell transplantation in first remission in hepatosplenic and angioimmunoblastic T-cell lymphoma.

Bibliografische Daten

OriginalspracheEnglisch
ISSN1545-5009
DOIs
StatusVeröffentlicht - 08.2020

Anmerkungen des Dekanats

© 2020 Wiley Periodicals, Inc.

PubMed 32452165